Literature DB >> 23159356

The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis.

Li-tian Chen1, Li-juan Lin, Lin-lin Zheng.   

Abstract

BACKGROUND/AIMS: The study aims to explore the expression of IMP3 in HCC and the correlation between its expression and prognosis.
METHODOLOGY: We collected several clinical and pathological files including 92 cases of HCC and 58 cases of adjacent liver tissues. Expression of IMP3 in these tissues was detected by immunohistochemistry, while compared with clinicopathological characteristics and expression of Ki-67. A χ2 test was used to analyze the relationship between expression of IMP3 and clinicοpathologic factors. The Kaplan-Meier survival curve was used to calculate survival rate. A Cox analysis was used to evaluate the relationship between index and patients’ lifetime.
RESULTS: The positive rate of IMP3 in HCC tissues was significantly higher than that in adjacent tissues. The expression of IMP3 was related to the histological differentiation of HCC, metastasis, the stage of ACJJ, the expression of Ki-67 and survival. The ACJJ stage, metastases and the expression of IMP3 were independent factors for the HCC patients’ survival.
CONCLUSIONS: IMP3, which is associated with tumor formation, invasion, tumor cell proliferation and so on, may become the target for inhabiting cell proliferation and the biomarker for predicting prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23159356     DOI: 10.5754/hge12855

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.

Authors:  Yihuan Luo; Fanghui Ren; Yongru Liu; Zhenhong Shi; Zhong Tan; Huojie Xiong; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models.

Authors:  Liem H Nguyen; Daisy A Robinton; Marc T Seligson; Linwei Wu; Lin Li; Dinesh Rakheja; Sarah A Comerford; Saleh Ramezani; Xiankai Sun; Monisha S Parikh; Erin H Yang; John T Powers; Gen Shinoda; Samar P Shah; Robert E Hammer; George Q Daley; Hao Zhu
Journal:  Cancer Cell       Date:  2014-08-11       Impact factor: 31.743

3.  IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma.

Authors:  Ji Young Park; Misun Choe; Yuna Kang; Sang Sook Lee
Journal:  Korean J Pathol       Date:  2014-04-28

4.  Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma.

Authors:  Jinhui Zhang; Yingfu Ou; Yibing Ma; Linlin Zheng; Xiaokang Zhang; Rongjun Xia; Fanyong Kong; Yue Shen; Shiqing Wang; Lijuan Lin
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

5.  Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.

Authors:  Luyao Chen; Yongpeng Xie; Xintao Li; Liangyou Gu; Yu Gao; Lu Tang; Jianwen Chen; Xu Zhang
Journal:  Onco Targets Ther       Date:  2017-06-06       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.